Vaccines and Infectious Disease

Subjects Enrolled in Vaccine Trials

PBMC Processing Capabilities and Central Laboratory Support

Average Retention Rate for Vaccine Trials

A Leader in High-Volume Vaccine Trials and Research Involving Hard-to-Reach Patients

The majority of the world’s leading Sponsors and CROs have made Meridian a preferred partner for their traditional and next-generation infectious disease programs. This is because Meridian provides a broad North American footprint to support rapid enrollment, even for seasonal studies involving specific cohorts (e.g., seniors, pediatrics, healthy).

As the largest member of the Platinum Research Network, Meridian provides access to more than 47 million patients globally. Meridian also offers a flexible clinical infrastructure to accommodate new technologies and novel approaches.

Meridian principal investigators have had their research published in prestigious industry journals, including Vaccine. These investigators are also sought after by Sponsors and CROs to provide counsel for vaccine-related protocol development.

Across all major and emerging indications, including anti-infectives and immunologics, Meridian supports research programs for drugs, medical devices, diagnostics, and combination products.

Therapeutic Experience

  • Anthrax
  • C. difficile
  • Dengue Fever
  • Ebola
  • H1N1 Influenza
  • H5N1 Influenza
  • Herpes
  • Human Metapneumovirus (hMPV)
  • Human Papillomavirus (HPV)
  • Influenza, Including Pediatric, Geriatric, and Off-Season
  • Japanese Encephalitis
  • Meningococcal
  • Parainfluenza
  • Pediatric Meningitis
  • Pediatric Influenza
  • Plague
  • Pneumococcal
  • Rabies
  • Respiratory Syncytial Virus (RSV), Including Maternal and Pediatric
  • Smallpox
  • Type 3 (PIV3)/RSV Combo
  • West Nile Virus

Cumulative Vaccine Trial Enrollment by Year

Meridian Vaccine Trial Enrollment

Types of Vaccine Trials Conducted

Meridian Vaccine Trial Indication
Average Enrollment for Vaccine Trials
Therapeutic Indications Supported
Sites Conducting Vaccine Trials
Principal Investigators Conducting Vaccine Trials
Government Icon

Government-Funded Research Experience

Regulatory Icon

In-House QA and Superb Regulatory Track Record

Patient Connection Icon

First-in-Human Trial Experience

Signature Icon

Trial Results Featured in Prestigious Publications, Including Vaccine


Let's Talk About Your Next Vaccine Trial